Your selections:
Who gets antidotes? Choosing the chosen few
- Buckley, Nicholas A., Dawson, Andrew H., Juurlink, David N., Isbister, Geoffrey K.
Warfarin poisoning with delayed rebound toxicity
- Berling, Ingrid, Mostafa, Ahmed, Grice, Jeffrey E., Roberts, Michael S., Isbister, Geoffrey K.
Treatment of sulfonylurea and insulin overdose
- Klein-Schwartz, Wendy, Stassinos, Gina L., Isbister, Geoffrey K.
Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely
- Ryan, Nicole M., Isbister, Geoffrey K.
The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity
- Page, Colin B., Ryan, Nicole M., Isbister, Geoffrey K.
The pharmacokinetics of sertraline in overdose and the effect of activated charcoal
- Cooper, Joyce M., Duffull, Stephen B., Saiao, Ana S., Isbister, Geoffrey K.
The influence of central nervous system depressant (CNS-D) drugs on driving performance and cognitive functions and recovery of cognitive functions following hospital treated deliberate self-poisoning (DSP) with CNS-D drugs
The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose
- Kumar, Venkata V. Pavan, Isbister, Geoffrey K., Duffull, Stephen B.
Risperidone overdose causes extrapyramidal effects but not cardiac toxicity
- Page, Colin B., Calver, Leonie A., Isbister, Geoffrey K.
Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
- Isbister, Geoffrey K., Bowe, Steven J., Dawson, Andrew, Whyte, Ian M.
- Isbister, Geoffrey K., Duffull, Stephen B
QTc abnormalities in deliberate self-poisoning with moclobemide
- Downes, Michael A, Whyte, Ian Macgregor, Isbister, Geoffrey K.
QT prolongation in mental health patients: contributory factors and clinical significance
Predicting Serotonin Toxicity in Serotonin Reuptake Inhibitor Overdose
- Cooper, Joyce, Duffull, Stephen B., Isbister, Geoffrey K.
- Li, Jingyun, Chiew, Angela L., Isbister, Geoffrey K., Duffull, Stephen B.
Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal
- van Gorp, Freek, Duffull, Stephen, Hackett, L. Peter, Isbister, Geoffrey K.
Paracetamol availability and recent changes in paracetamol poisoning: is the 1998 legislation limiting availability of paracetamol being followed?
- Greene, S. L., Dargan, P. I., Leman, P., Jones, A. L.
- Conway, A., Valerio, H., Dunlop, A., Montebello, M., Whitton, G., Reid, D., Lam, T., Alavi, M., Silk, D., Marshall, A. D., Treloar, C., Dore, G. J., Peacock, A., Grebely, J, ETHOS Engage Study Group,, Degenhardt, L., Hayllar, J., Harrod, M. E., Henderson, C., Read, P., Gilliver, R., Christmass, M.
- Oxley, Stewart O. C., Dassanayake, Tharaka L., Carter, Gregory L., Whyte, Ian, Jones, Alison L., Cooper, Gavin, Michie, Patricia T.
Modified release paracetamol overdose: a prospective observational study (ATOM-3)
- Chiew, Angela L., Isbister, Geoffrey K., Page, Colin B., Kirby, Katharine A., Chan, Betty S. H., Buckley, Nicholas A.
Are you sure you would like to clear your session, including search history and login status?